TY - JOUR
T1 - Joining forces to prevent dementia
T2 - The International Research Network On Dementia Prevention (IRNDP)
AU - Anstey, Kaarin J.
AU - Peters, Ruth
AU - Clare, Linda
AU - Lautenschlager, Nicola T.
AU - Dodge, Hiroko H.
AU - Barnes, Deborah E.
AU - Shahar, Suzana
AU - Brodaty, Henry
AU - Rees, Glenn
PY - 2017/11/1
Y1 - 2017/11/1
N2 - Dementia is a neurodegenerative disorder with global impact, with the largest proportion of cases occurring in low- and middle-income countries. It is estimated that there are 46.8 million cases globally with approximately 10 million new cases each year or a new case occurring every 3 sec (Prince et al., 2015). For comparison there are 36.7 million HIV cases with an estimated 2 million new cases each year (WHO, 2017). The rise in dementia prevalence is largely due to population ageing, with the oldest being at highest risk. To date there are no diseases modifying medications for Alzheimer's disease or the other causes of dementia. Academics and research groups are increasingly focused on prevention or delay of dementia (Brayne and Miller, 2017) and a number of organizations now prioritize dementia, indicating a strong and coherent international effort to address this problem. Examples include the World Health Organisation (WHO), which has established a Global Dementia Observatory; the World Dementia Council; the Organisation for Economic Co-operation and Development (OECD); the U.S. National Alzheimer's Project Act (NAPA); and the Global Council on Brain Health.
AB - Dementia is a neurodegenerative disorder with global impact, with the largest proportion of cases occurring in low- and middle-income countries. It is estimated that there are 46.8 million cases globally with approximately 10 million new cases each year or a new case occurring every 3 sec (Prince et al., 2015). For comparison there are 36.7 million HIV cases with an estimated 2 million new cases each year (WHO, 2017). The rise in dementia prevalence is largely due to population ageing, with the oldest being at highest risk. To date there are no diseases modifying medications for Alzheimer's disease or the other causes of dementia. Academics and research groups are increasingly focused on prevention or delay of dementia (Brayne and Miller, 2017) and a number of organizations now prioritize dementia, indicating a strong and coherent international effort to address this problem. Examples include the World Health Organisation (WHO), which has established a Global Dementia Observatory; the World Dementia Council; the Organisation for Economic Co-operation and Development (OECD); the U.S. National Alzheimer's Project Act (NAPA); and the Global Council on Brain Health.
UR - http://www.scopus.com/inward/record.url?scp=85030851172&partnerID=8YFLogxK
U2 - 10.1017/S1041610217001685
DO - 10.1017/S1041610217001685
M3 - Review article
C2 - 28899450
AN - SCOPUS:85030851172
SN - 1041-6102
VL - 29
SP - 1757
EP - 1760
JO - International Psychogeriatrics
JF - International Psychogeriatrics
IS - 11
ER -